Jaswant Singh Khera

WEP Group Holdings Ltd. was founded in 2017 and is a British company that creates broader treatment access solutions for patients worldwide. The company is based in London, UK, and has subsidiaries in the United Kingdom. The company works with companies to set up and manage expanded access programs (EAPs) and post-approval named patient programs (PA-NPPs). EAPs allow sponsors to supply investigational drugs to patients who cannot enroll in active studies, while PA-NPPs allow sponsors to provide approved drugs to patients who need them.

Part of WEP Group Holdings Ltd., WE Pharma Ltd. creates broader treatment access solutions for patients worldwide. The company is based in London, UK. The British company works with companies to set up and manage expanded access programs (EAPs) and post-approval named patient programs (PA-NPPs). EAPs allow sponsors to supply investigational drugs to patients who cannot enroll in active studies, while PA-NPPs allow sponsors to provide approved drugs to patients who need them.

WEP Group Holdings Ltd. was founded in 2017 and is a British company that creates broader treatment access solutions for patients worldwide. The company is based in London, UK, and has subsidiaries in the United Kingdom. The company works with companies to set up and manage expanded access programs (EAPs) and post-approval named patient programs (PA-NPPs). EAPs allow sponsors to supply investigational drugs to patients who cannot enroll in active studies, while PA-NPPs allow sponsors to provide approved drugs to patients who need them.